BioMarin Pharmaceuticals BMRN FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's FX effect on cash?
- BioMarin Pharmaceuticals (BMRN) reported FX effect on cash of $1.41M in Q1 2026.
- How has BioMarin Pharmaceuticals's FX effect on cash changed year-over-year?
- BioMarin Pharmaceuticals's FX effect on cash increased by 199.6% year-over-year, from -$1.42M to $1.41M.
- What does FX effect on cash mean?
- The change in cash value caused solely by currency exchange rate fluctuations.
- How do you interpret FX effect on cash?
- Large values indicate significant exposure to foreign currency volatility and potential translation risk.
- How does FX effect on cash compare across companies?
- Common for multinational corporations; usually small relative to total cash unless significant currency devaluation occurs.